Entheon Biomedical Corp. (CSE:ENBI)

Canada flag Canada · Delayed Price · Currency is CAD
0.0950
0.00 (0.00%)
Oct 28, 2025, 10:15 AM EDT
Market Cap1.32M
Revenue (ttm)n/a
Net Income (ttm)-342.81K
Shares Out13.86M
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume37,650
Average Volume11,693
Open0.1000
Previous Close0.0950
Day's Range0.0800 - 0.1000
52-Week Range0.0700 - 0.3800
Beta1.42
RSI57.61
Earnings DateMar 5, 2026

About Entheon Biomedical

Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Timothy Ko
Employees 1
Stock Exchange Canadian Securities Exchange
Ticker Symbol ENBI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.